Middle East and North Africa Region
HPV Regional Profile
11202
cases in 2018
7601
deaths in 2018
Libya and the UAE are the only countries in the region that have the HPV vaccine in their national immunization programs.
General Information
Human Papillomavirus
Burden of HPV infection
Across countries in the Middle East and North Africa (MENA) region (as defined by UNAIDS), between 0.2% and 13.9% of people are estimated to have HPV, which causes approximately 70% of invasive cervical cancers.1
Link between HPV infection and cancer
Human papillomavirus (HPV), which is sexually transmitted, is the most common viral infection of the reproductive tract. Most sexually active women and men will be infected at some point in their lives and some may be repeatedly infected.
There are many types of HPV, and many do not cause problems. However, certain types of HPV can persist and progress to cancer. Cervical cancer is by far the most common HPV-related disease. Nearly all cases of cervical cancer can be attributable to HPV infection.4
Burden of cervical cancer
Cervical cancer causes at least 7,601 deaths among women annually in the MENA region (as defined by UNAIDS). Between 2012 and 2018, the number of deaths every year due to cervical cancer doubled in most countries in the region.1,2 If decisive action is not taken at the national and regional levels, annual deaths due to the preventable disease will double again by 2040, reaching 15,728 deaths per year.3 In the region, at least 11,202 women are newly diagnosed with cervical cancer each year.
Across the MENA region, incidence and mortality rates vary. For example, Somalia and Morocco have the highest incidence and mortality rates, with 24.0 and 17.2 women per 100,000 being newly diagnosed with cervical cancer annually and at least 21.9 and 12.6 women per 100,000 dying due to cervical cancer per year, respectively. Whereas Iran, Iraq and Yemen have the lowest (around 2 per 100,000 women are diagnosed per year and about 1 per 100,000 die because of cervical cancer annually).2
Algeria
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
1594
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
1066
Read more
Jordan
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
104
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
61
Read more
Kuwait
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
59
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
59
Read more
Lebanon
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
192
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
125
Read more
Libya
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
319
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
127
Read more
Morocco
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
3388
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
2465
Read more
Qatar
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
19
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
12
Read more
Saudi Arabia
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
316
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
158
Read more
The United Arab Emirates
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
108
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
56
Read more
Tunisia
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
285
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
199
Read more
Turkey
NEW CASES OF CERVICAL CANCER IN 2018 (TOTAL)
2356
DEATHS FROM CERVICAL CANCER IN 2018 (TOTAL)
1280
Read more
-
Anfinan, Nisreen M. “Physician’s Knowledge and Opinions on Human Papillomavirus Vaccination: A Cross-Sectional Study, Saudi Arabia.” BMC Health Services Research, vol. 19, no. 1, Dec. 2019, p. 963, https://doi.org/10.1186/s12913-019-4756-z.
-
Mousa Manar, et al. “Prevalence of Human Papillomavirus in Jeddah, Saudi Arabia.” Annals of Saudi Medicine, vol. 39, no. 6, Dec. 2019, pp. 403–09, https://doi.org/10.5144/0256-4947.2019.403.
-
Dochez, Carine, et al. “Strengthening National Teams of Experts to Support HPV Vaccine Introduction in Eastern Mediterranean Countries: Lessons Learnt and Recommendations from an International Workshop.” Vaccine, Nov. 2019, https://doi.org/10.1016/j.vaccine.2019.11.027.
-
Tuncer, Hasan Aykut. “Women’s Knowledge, Awareness and Attitudes toward Newly Implemented National HPV-Based Screening in Turkey.” Journal of Cancer Policy, Nov. 2019, p. 100205, https://doi.org/10.1016/j.jcpo.2019.100205.
-
Messoudi, Wadie, et al. “Cervical Cancer Prevention in Morocco: A Model-Based Cost-Effectiveness Analysis.” Journal of Medical Economics, vol. 22, no. 11, Nov. 2019, pp. 1153–59, https://doi.org/10.1080/13696998.2019.1624556.
-
Lamtali, S., and M. Loukid. “Knowledge of Cervical Cancer and Uptake of Screening Test Among Women in the Region of Marrakesh, Morocco.” SN Comprehensive Clinical Medicine, Oct. 2019, https://doi.org/10.1007/s42399-019-00148-4.
-
Hodaei, Masumeh Haj, et al. “Cloning and Expression of the L1 Immunogenic Protein of Human Papillomavirus Genotype 16 by Using Lactobacillus Expression System.” Gene Reports, Oct. 2019, p. 100521, https://doi.org/10.1016/j.genrep.2019.100521.
-
Heena, Humariya, et al. “Knowledge, Attitudes, and Practices towards Cervical Cancer and Screening amongst Female Healthcare Professionals: A Cross-Sectional Study.” Journal of Oncology, vol. 2019, Oct. 2019, pp. 1–9, https://doi.org/10.1155/2019/5423130.
-
Belglaiaa, Essaada, and Christiane Mougin. “Le Cancer Du Col de l’utérus : État Des Lieux et Prévention Au Maroc.” Bulletin Du Cancer, Oct. 2019, https://doi.org/10.1016/j.bulcan.2019.08.020.
-
Bahr, Sarah, et al. “Cost–Benefit Analysis of a Projected National Human Papilloma Virus Vaccination Programme in Lebanon.” Eastern Mediterranean Health Journal, vol. 25, no. 10, Oct. 2019, pp. 715–21, https://doi.org/10.26719/2019.25.10.715.
-
Moore, K., et al. “992OFORWARD I (GOG 3011): A Phase III Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (FRa)-Targeting Antibody-Drug Conjugate (ADC), versus Chemotherapy in Patients (Pts) with Platinum-Resistant Ovarian Cancer (PROC).” Annals of Oncology, vol. 30, no. Supplement_5, Oct. 2019, p. mdz250, https://doi.org/10.1093/annonc/mdz250.
-
Belglaiaa, E., and C. Mougin. “[Cervical cancer: Current situation and management in Morocco].” Bulletin du cancer, Oct. 2019, https://doi.org/10.1016/j.bulcan.2019.08.020.
-
Almazrou, Sarah, et al. “Knowledge, Attitudes, and Practices of Saudi Physicians Regarding Cervical Cancer and the Human Papilloma Virus Vaccine.” Journal of Infection and Public Health, Sept. 2019, https://doi.org/10.1016/j.jiph.2019.09.002.
-
Alyafeai, Zaid, and Lahouari Ghouti. “A Fully-Automated Deep Learning Pipeline for Cervical Cancer Classification.” Expert Systems with Applications, Sept. 2019, p. 112951, https://doi.org/10.1016/j.eswa.2019.112951.
-
Abu-Lubad, Mohammad A., et al. “Human Papillomavirus as an Independent Risk Factor of Invasive Cervical and Endometrial Carcinomas in Jordan.” Journal of Infection and Public Health, Sept. 2019, https://doi.org/10.1016/j.jiph.2019.08.017.
-
Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Statistics. Retrieved December 19, 2018, from http://www.hpvcentre.net/datastatistics.php
-
Cancer Today. (2018, September). Retrieved October 19, 2018, from https://gco.iarc.fr/.
-
Cancer Tomorrow. (2018, September). Retrieved October 19, 2018, from https://gco.iarc.fr/.
-
Human papillomavirus (HPV) and cervical cancer. (2018, February 15). Retrieved November 2, 2018, from http://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cance